Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease

被引：0
作者：
Clifford J. Bailey
Caroline Day
Srikanth Bellary
机构：
[1] Aston University,Life and Health Sciences
来源：
Current Diabetes Reports | 2022年 / 22卷
关键词：
Sodium-glucose co-transporter-2 (SGLT2) inhibitors; Diabetic kidney disease; Chronic kidney disease; Albuminuria; Acute kidney disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：39 / 52
页数：13
相关论文
共 50 条
[41]   Multiple Effects of SGLT2 Inhibitors [J].
Nagasu, Hajime .
JMA JOURNAL, 2024,
[42]   Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia [J].
Durcan, Emre ;
Ozkan, Serbay ;
Saygi, Halil Ibrahim ;
Dincer, Mevlut Tamer ;
Korkmaz, Ozge Polat ;
Sahin, Serdar ;
Karaca, Cebrail ;
Sulu, Cem ;
Bakir, Alev ;
Ozkaya, Hande Mefkure ;
Trabulus, Sinan ;
Guzel, Elif ;
Seyahi, Nurhan ;
Gonen, Mustafa Sait .
JOURNAL OF DIABETES, 2022, 14 (04) :236-246
[43]   Renoprotective Effects of SGLT2 Inhibitors [J].
Vallon, Volker .
HEART FAILURE CLINICS, 2022, 18 (04) :539-549
[44]   SGLT2 inhibitors in patients with type 2 diabetes and renal disease: overview of current evidence [J].
Davidson, Jaime A. .
POSTGRADUATE MEDICINE, 2019, 131 (04) :251-260
[45]   Uric acid and the cardio-renal effects of SGLT2 inhibitors [J].
Bailey, Clifford J. .
DIABETES OBESITY & METABOLISM, 2019, 21 (06) :1291-1298
[46]   The renal effects of SGLT2 inhibitors and a mini-review of the literature [J].
Andrianesis, Vasileios ;
Glykofridi, Spyridoula ;
Doupis, John .
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2016, 7 (5-6) :212-228
[47]   Comment on "The efficacy and safety of SGLT2 inhibitors in patients with non-diabetic chronic kidney disease" [J].
Chen, I. -Wen ;
Chang, Li-Chen ;
Hung, Kuo-Chuan .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (06) :2115-2116
[48]   Comment on “The efficacy and safety of SGLT2 inhibitors in patients with non-diabetic chronic kidney disease” [J].
I.-Wen Chen ;
Li-Chen Chang ;
Kuo-Chuan Hung .
International Urology and Nephrology, 2024, 56 :2115-2116
[49]   SGLT2 Inhibitors Decrease Overhydration and Proteasuria in Patients with Chronic Kidney Disease: A Longitudinal Observational Study [J].
Schork, Anja ;
Eberbach, Marie-Luise ;
Bohnert, Bernhard N. ;
Woern, Matthias ;
Heister, David J. ;
Eisinger, Felix ;
Vogel, Elisabeth ;
Heyne, Nils ;
Birkenfeld, Andreas L. ;
Artunc, Ferruh .
KIDNEY & BLOOD PRESSURE RESEARCH, 2024, 49 (01) :124-134
[50]   Class effects of SGLT2 inhibitors on cardiorenal outcomes [J].
Kluger, Aaron Y. ;
Tecson, Kristen M. ;
Lee, Andy Y. ;
Lerma, Edgar V. ;
Rangaswami, Janani ;
Lepor, Norman E. ;
Cobble, Michael E. ;
McCullough, Peter A. .
CARDIOVASCULAR DIABETOLOGY, 2019, 18 (01)
12345